AVEXXIN
Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases at the Norwegian University of Science and Technology. Avexxin's goal is to create a therapeutic company based on the discovery and development of novel therapeutics that address the fundamental mechanisms involved in inflammatory diseases.
AVEXXIN
Industry:
Biotechnology Pharmaceutical
Founded:
2005-01-01
Address:
Trondheim, Sor-Trondelag, Norway
Country:
Norway
Website Url:
http://www.avexxin.com
Total Employee:
11+
Status:
Closed
Contact:
+47 73 59 61 07
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving IIS IIS 7 Swedish Server Location
Similar Organizations
Blueberry Therapeutics
Blueberry Therapeutics focuses on developing medicines for inflammatory and infectious diseases.
Current Employees Featured
Investors List
Sarsia Seed Management
Sarsia Seed Management investment in Venture Round - Avexxin
Leiv Eiriksson Invest
Leiv Eiriksson Invest investment in Venture Round - Avexxin
Official Site Inspections
http://www.avexxin.com
- Host name: redirect1-1.ilait.se
- IP address: 62.109.34.30
- Location: Sölvesborg Sweden
- Latitude: 56.0521
- Longitude: 14.5753
- Timezone: Europe/Stockholm
- Postal: 294 32
More informations about "Avexxin"
Avexxin Oncology Company Presentation v4 - Coegin Pharma
The history of Avexxin Oncology’s drug candidate AVX420 with a specific mode of action inhibiting cPLA2! 1. J Med Chem. 2014 Sep 25;57(18):7523-35, 2. HussinA, 2016, Effects of …See details»
Avexxin - Crunchbase Company Profile & Funding
Avexxin has 2 investors including Sarsia Seed Management and Leiv Eiriksson Invest. When was the last funding round for Avexxin? Avexxin closed its last funding round on Jan 10, 2011 from …See details»
Avexxin Company Profile | Management and Employees List
Avexxin Profile and History. Avexxin was established in March 2005 as a result of several years of scientific work at Prof. Berit Johansen's laboratory at the Norwegian University of Science and …See details»
Avexxin - Overview, News & Similar companies | ZoomInfo.com
View Avexxin (www.avexxin.com) location in Sor-Trondelag, Norway , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Avexxin Oncology AS - 928 002 136 - Trondheim - Se Regnskap
Avexxin Oncology AS. Org nr 928 002 136. Kredittrapport premium. Oppdatert kredittinformasjon og rating. 295,- kr. Firmarapport premium. Full firma og kredittrapport. 1 495,- kr. Komplett …See details»
Coegin Pharma - Products, Competitors, Financials, Employees ...
Coegin Pharma is a biotechnology company that develops drug candidates and derma cosmetic products. The company's offerings include treatments for hair growth, skin pigmentation, heart …See details»
Avexxin AS - Company Profile and News - Bloomberg Markets
Company profile page for Avexxin AS including stock price, company news, executives, board members, and contact informationSee details»
Avexxin Oncology_non-confidential_MAR 2023_webpage
The history of Avexxin Oncology’s drug candidate AVX420 with a specific mode of action inhibiting cPLA2! 1. J Med Chem. 2014 Sep 25;57(18):7523-35, 2. HussinA, 2016, Effects of …See details»
Avexxin - Contacts, Employees, Board Members, Advisors & Alumni
Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Avexxin - Crunchbase
Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases Search Crunchbase Start Free TrialSee details»
Avexxin Asset Profile - Preqin
Www.avexxin.com Company Stage Series B Total Amount Raised Subscriber access only Time to go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, …See details»
He is heading a new company for the development of Coegin’s …
Oct 31, 2022 The fact that Avexxin Oncology is established in Norway is partly due to the fact that the researcher behind AVX420, Professor Berit Johansen, lives there and partly to the fact …See details»
Coegin Pharma (fka Avexxin) - VentureRadar
"Coegin Pharma AB is a biotechnology company that focuses on the development of small molecule therapies aimed at the key enzyme cPLA2a. cPLA2a is a member of the …See details»
Coegin Pharma establishes new cancer company in Norway
Oct 24, 2022 Coegin Pharma establishes new cancer company in Norway, appoints CEO Danish national John Zibert will be the CEO of Avexxin Oncology, which is developing a new …See details»
Coegin Pharma: Coegin Pharma presenterar bolagsinformation …
Oct 28, 2022 Coegin Pharma AB ("Coegin Pharma") meddelade nyligen om det nyetablerade dotterbolaget Avexxin Oncology AS ("Avexxin Oncology") och presenterar nu ytterligare …See details»
Avexxin Staff Directory & Email Format - ContactOut
Explore Avexxin staff directory for direct access to contact details on 3 employees including email format, email address and phone numbers.See details»
Avexxin - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Lead Investors . Jan 10, 2011: Venture Round - Avexxin . 2: obfuscated. …See details»
Avexxin AS - Scrip
Oct 23, 2012 Avexxin AS is betting that the novel molecular target identified by one of its co-founders will enable development of a drug capable of treating inflammatory skin diseases like …See details»
Avex Inc. - Audiovisual Identity Database
Background. Avex Inc. (Japanese: エイベックス株式会社, commonly known as Avex and stylized as avex, an acronym of Audio Visual Expert), is a Japanese entertainment conglomerate led …See details»
Avexxin - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Avexxin uses 12 technology products and services including HTML5, F5 NGINX, and jQuery, according to G2 Stack. Avexxin is actively using 5 technologies for its website, according to …See details»